GSK’S Arixtra “Approvable” For Acute Coronary Syndromes
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm is seeking FDA approval of fondaparinux for treatment of unstable angina or non-ST segment elevation myocardial infarction and ST-segment elevation MI.